(NasdaqGM:NRIX), SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to bexobrutideg (NX-5948) for the treatment of lymphoplasmacytic lymphoma. Bexobrutideg is […]

(TSX:AYA),(OTC US:AYASF),(Other OTC:AYASF), MONTREAL, July 07, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce new high-grade drill exploration results from its 2025 program at Boumadine in the Kingdom of Morocco. Today's results also extend the Imariren mineralized trend to 1 kilometer (“km”)

(TSX-V:IVS), TORONTO, July 07, 2025 (GLOBE NEWSWIRE) — Inventus Mining Corp. (TSXV: IVS) (“Inventus” or the “Company”) is pleased to announce final assays from grade-control drilling of the 10,000-tonne Trench 1 Bulk Sample Site on its 100%-owned Pardo Gold Project, located 65 km northeast of Sudbury, Ontario. Highlights Assay results from grade-control drilling at the

(TSX:BLX), MONTREAL, July 07, 2025 (GLOBE NEWSWIRE) — Boralex Inc. (TSX: BLX) (“Boralex” or the “Company”) announces the closing of an additional corporate financing of $250 million by way of an unsecured subordinated loan with a term of 8 years. The investment is made by La Caisse (formerly CDPQ), which is providing an amount of

Completion of enrollment achieved nearly one year ahead of schedule Primary analysis anticipated two years post-treatment TOKYO and LONDON and BOSTON, July 07, 2025 (GLOBE NEWSWIRE) — Orchard Therapeutics, a Kyowa Kirin company, today announced the last patient has been treated in a registrational trial evaluating the efficacy and safety of OTL-203, an investigational hematopoietic

(NASDAQ:UNCY), LOS ALTOS, Calif., July 07, 2025 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, M.D., Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 4th Annual Kidney Virtual Conference on

CORRECTION – Dr. Anosh Ahmed Announces Major Expansion of COVID Testing Contracts Across U.S. and International Markets Dr. Anosh Ahmed expands U.S. and international COVID testing contracts with focus on compliance, fraud prevention, and trusted public health services GlobeNewswire July 07, 2025 CHICAGO, July 07, 2025 (GLOBE NEWSWIRE) — In a release issued under the

(NasdaqGM:SHLS), PORTLAND, Tenn., July 07, 2025 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (the “Company”) (Nasdaq: SHLS) today announced that the Company will release its second quarter 2025 results before market open on Tuesday, August 5, 2025, to be followed by a conference call at 8:00 a.m. (Eastern Time) on the same day. Interested investors

(Other OTC:OTCM),(OTC US:OTCM),(Other OTC:VRMWW), NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Vroom, Inc. (“Vroom”) (OTCQX: VRMWW), a leading automotive finance company and a data and AI-powered analytics and digital services platform supporting the automotive industry,

(Other OTC:MHCUF),(OTC US:MHCUF),(TSX:MHC-U),(TSX:MHC-UN), Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, July 07, 2025 (GLOBE NEWSWIRE) — Flagship Communities Real Estate Investment Trust (TSX: MHC.U) (TSX:MHC.UN) (“Flagship” or the “REIT”) today announced that senior management will host a conference call on Thursday, August 7, 2025 at 8:30 a.m. ET